Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.2B |
| 3 |
Oracle
ORCL
|
+$945M |
| 4 |
Meta Platforms (Facebook)
META
|
+$913M |
| 5 |
JPMorgan Chase
JPM
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.64B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.16B |
| 3 |
Qualcomm
QCOM
|
+$1.02B |
| 4 |
Tesla
TSLA
|
+$911M |
| 5 |
Mastercard
MA
|
+$837M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.54% |
| 2 | Healthcare | 13.79% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Financials | 10.34% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
B&G Foods
BGS
$274M
| $519K | ﹤0.01% |
37,285
-78,500
| -68% | -$1.13M |
|
2502
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $512K | ﹤0.01% |
14,902
-918
| -6% | -$31.4K |
|
2503
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $509K | ﹤0.01% |
9,883
+2,285
| +30% | +$114K |
|
|
MRC
2504
DELISTED
MRC Global
MRC
| $509K | ﹤0.01% |
50,540
+48,666
| +2,597% | +$460K |
|
2505
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $508K | ﹤0.01% |
7,802
+3,345
| +75% | +$204K |
|
2506
Emergent Biosolutions
EBS
$228M
| $508K | ﹤0.01% |
69,053
+30,666
| +80% | +$284K |
|
2507
Monarch Casino & Resort
MCRI
$2.18B
| $507K | ﹤0.01% |
7,200
+114
| +2% | +$7.95K |
|
|
BLUE
2508
DELISTED
bluebird bio
BLUE
| $507K | ﹤0.01% |
7,707
+2,252
| +41% | +$165K |
|
|
ALLK
2509
DELISTED
Allakos
ALLK
| $505K | ﹤0.01% |
115,717
+6,981
| +6% | +$31.4K |
|
|
AGEN
2510
Agenus
AGEN
$282M
| $503K | ﹤0.01% |
15,711
+15,377
| +4,604% | +$492K |
|
2511
Energy Fuels
UUUU
$3.53B
| $501K | ﹤0.01% |
80,616
-4,014
| -5% | -$23.6K |
|
2512
Tompkins Financial
TMP
$1.4B
| $501K | ﹤0.01% |
8,986
-447
| -5% | -$25.7K |
|
2513
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $500K | ﹤0.01% |
10,861
+6,881
| +173% | +$318K |
|
2514
iShares US Aerospace & Defense ETF
ITA
$15B
| $496K | ﹤0.01% |
4,254
+195
| +5% | +$22.2K |
|
2515
WisdomTree US MidCap Dividend Fund
DON
$4.07B
| $491K | ﹤0.01% |
11,683
+2,523
| +28% | +$102K |
|
2516
Atlanta Braves Holdings Series A
BATRA
$3.42B
| $489K | ﹤0.01% |
11,957
+1,001
| +9% | +$38.7K |
|
|
RDFN
2517
DELISTED
Redfin
RDFN
| $489K | ﹤0.01% |
39,371
+608
| +2% | +$5.92K |
|
2518
WisdomTree US Total Dividend Fund
DTD
$1.69B
| $489K | ﹤0.01% |
7,868
-844
| -10% | -$51.1K |
|
2519
Supernus Pharmaceuticals
SUPN
$2.75B
| $488K | ﹤0.01% |
16,250
-651
| -4% | -$22.8K |
|
|
ICPT
2520
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $488K | ﹤0.01% |
44,156
+180
| +0.4% | +$2.51K |
|
2521
Vitamin Cottage Natural Grocers
NGVC
$630M
| $487K | ﹤0.01% |
39,739
+167
| +0.4% | +$1.88K |
|
2522
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.4B
| $483K | ﹤0.01% |
12,444
+7,153
| +135% | +$266K |
|
2523
iShare MSCI Eurozone ETF
EZU
$9.88B
| $480K | ﹤0.01% |
10,482
+2,496
| +31% | +$114K |
|
2524
MacroGenics
MGNX
$257M
| $478K | ﹤0.01% |
89,405
+22,508
| +34% | +$139K |
|
2525
Karyopharm Therapeutics
KPTI
$44.4M
| $476K | ﹤0.01% |
17,739
+10,073
| +131% | +$434K |
|
Similar funds
Fidelity Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Fidelity Investments held 5,715 positions worth $1.19T, up 9.1% from $1.09T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fidelity Investments's Q2 2023 filing shows 467 new, 2,358 increased, 2,086 reduced and 337 closed positions. Its largest new stake was Crane Co: 6,604,359 shares worth $589M. The largest sale was NVIDIA, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2023 buy was Crane Co: 6,604,359 shares worth $589M.
- Fidelity Investments added most to Microsoft in Q2 2023, an estimated $3B increase.
- Fidelity Investments's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $1.64B.
- Fidelity Investments fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $123M.
- Fidelity Investments's ten largest holdings make up 30% of its $1.19T portfolio in Q2 2023.
- Fidelity Investments opened 467 new positions and closed 337 in Q2 2023.
- Fidelity Investments's portfolio value rose 9.1% quarter-over-quarter to $1.19T.
Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.